IFF Inaugurates New Experimental Field in Grasse

Written by Emily J. Thompson, Senior Investment Analyst

Source: Newsfilter

Updated: 2 days ago

0mins

IFF-2.54%

Explore Agentic TradingLet AI Trade for You

Source: Newsfilter

Field Inauguration: IFF's new 1.8-hectare Domaine des Naturels LMR experimental field in Grasse aims to advance research in natural ingredients by integrating traditional and modern agricultural techniques, thereby enhancing innovation and product differentiation in the fragrance industry.
Sustainable Innovation: The field not only preserves Grasse's agricultural heritage but also promotes ecological balance through diversified water sourcing and biodiversity initiatives, allowing for real-world exploration of plant varieties and optimization of cultivation techniques to enhance agricultural system resilience.
Education and Heritage: Domaine des Naturels LMR will gradually host the LMR Naturals Academy, offering training programs and hands-on experiences to deepen customer and perfumer understanding of sourcing and cultivating natural materials, ensuring the transmission of specialized knowledge.
Global Network Connection: Since acquiring LMR Naturals in 2000, IFF has steadily invested in Grasse, establishing a global research network spanning Brazil, the United States, and Asia, enabling knowledge generated at Domaine des Naturels LMR to extend across IFF's 14 innovation platforms, further elevating standards in natural ingredients.

Trade with 70% Backtested Accuracy

Stop guessing "Should I Buy IFF?" and start using high-conviction signals backed by rigorous historical data.

Analyst Views on IFF

Wall Street analysts forecast IFF stock price to rise

9 Analyst Rating

6 Buy

3 Hold

0 Sell

Moderate Buy

Current: 78.030

Low

68.00

Averages

80.66

High

89.00

Current: 78.030

Low

68.00

Averages

80.66

High

89.00

JPMorgan

NULL -> Overweight

maintain

$90 -> $92

2026-05-07

Reason

JPMorgan

Price Target

$90 -> $92

AI Analysis

2026-05-07

maintain

NULL -> Overweight

Reason

JPMorgan raised the firm's price target on IFF to $92 from $90 and keeps an Overweight rating on the shares.

Oppenheimer

Outperform

maintain

$88 -> $90

2026-05-07

Reason

Oppenheimer

Price Target

$88 -> $90

2026-05-07

maintain

Outperform

Reason

Oppenheimer raised the firm's price target on IFF to $90 from $88 and keeps an Outperform rating on the shares. The firm notes IFF delivered a strong Q1, providing a buffer against the uncertain macro backdrop ahead, maintaining its FY26 guide. While Oppenheimer expects demand will continue to dictate shares' performance, the firm sees the impending update on Food Ingredients as a key catalyst over the coming quarter, capping a years-long emphasis on rightsizing the portfolio and balance sheet.

Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for IFF

Unlock Now

About IFF

International Flavors & Fragrances Inc. is a creator and manufacturer of products for application in food, beverage, health and biosciences, scent and complementary adjacent products. Its segment includes Taste, Food Ingredients, Health & Biosciences, and Scent. The Taste segment consists of a range of flavor compounds and natural taste solutions used in food and beverage applications. The Food Ingredients segment includes a broad portfolio of natural and plant-based specialty ingredients that provide texturizing and food protection capabilities, as well as pea protein solutions, emulsifiers, and sweeteners. Its Health & Biosciences segment consists of the development and production of an advanced biotechnology-derived portfolio of enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications. Its Scent segment creates fragrance compounds and fragrance ingredients that are integral elements in perfumes and household and personal care products.

About the author

Emily J. Thompson

Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.

IFF Sells Food Ingredients Business for $4.3B

1 day agoseekingalpha

Significant Transaction: IFF has entered into an agreement to sell its food ingredients business to CVC Capital Partners for approximately $4.3 billion, reflecting a robust enterprise value-to-EBITDA multiple of about 10x, indicating strong market interest and valuation recognition for the business.
Equity Retention for Collaboration: By retaining a 10% minority equity interest valued at around $200 million, IFF ensures ongoing collaboration with the food ingredients business, allowing both IFF and its shareholders to participate in future value creation, thereby enhancing strategic flexibility.
Clear Use of Proceeds: IFF expects to receive approximately $3.8 billion in net cash proceeds at closing, which will be directed towards debt reduction, targeted share repurchases, and high-return opportunities within its core portfolio, optimizing capital structure and enhancing shareholder value.
Accelerated Strategic Transformation: This transaction is viewed as a crucial milestone in IFF's portfolio optimization strategy, with CEO Erik Fyrwald stating that by simplifying the business portfolio, IFF will accelerate innovation, drive R&D investment, and more effectively integrate biotechnology and natural capabilities to address long-term trends in health and sustainability.

IFF Sells Food Ingredients Business for $4.3 Billion

1 day agoNASDAQ.COM

Transaction Value: International Flavors & Fragrances Inc. (IFF) has signed a deal to sell its Food Ingredients business to CVC Capital Partners for approximately $4.3 billion, with the transaction expected to close by the end of Q2 2027, marking a significant milestone in the company's portfolio optimization strategy.
Cash Proceeds: IFF anticipates receiving around $3.8 billion in net cash proceeds from the transaction, which will be utilized to repay debt, fund share repurchases, and reinvest in high-return growth opportunities within its core portfolio, thereby enhancing financial flexibility.
Earnings Impact: Although the sale is expected to dilute adjusted earnings per share in the first 12 months post-close, IFF plans to improve profitability through capital deployment and addressing stranded overhead costs, demonstrating confidence in future growth.
Annual Guidance: IFF has reaffirmed its annual guidance for fiscal 2026, expecting adjusted operating EBITDA between $2.05 billion and $2.15 billion, with sales projected between $10.5 billion and $10.8 billion, indicating a stable growth outlook for its core business.

IFF Sells Food Ingredients Business to Focus on High-Growth Segments

1 day agoNewsfilter

Significant Transaction Value: IFF has entered into an agreement with CVC Capital to sell its Food Ingredients business for approximately $4.3 billion, with an EBITDA multiple of about 10x, which is expected to enhance the company's financial flexibility and shareholder value.
Equity Retention for Collaboration: By retaining a 10% minority stake valued at around $200 million, IFF ensures continued collaboration with the Food Ingredients business while participating in future value creation, reflecting the company's confidence in the business's prospects.
Focus on Core Businesses: This transaction marks a strategic transformation for IFF towards its innovation-driven segments—Taste, Scent, and Health & Biosciences—expected to improve cash flow characteristics and profitability, driving sustainable long-term growth.
Planned Use of Proceeds: IFF anticipates receiving approximately $3.8 billion in net cash proceeds at closing, which will be allocated towards debt reduction, share repurchases, and reinvestment in high-return growth opportunities, although it may dilute adjusted EPS in the short term.